Appendix 2: statistical modeling procedures
Statistical modeling procedures were used to estimate treatment effects and explore the relationships of target variables to treatment and prognostic covariates that were determined at the start of the study. Analyses that used covariates that were part of the minimization process for assigning study treatment in BENEFIT were based on the covariate information in case report forms (CRFs). Efficacy analyses were performed in the full analysis set, which included all subjects with at least one administration of study drug during the BENEFIT study. Treatment groups were considered as randomized according to the minimization procedure regardless of the kind of study treatment received.
Generally, efficacy analyses, including time to CDMS, were also performed for the subset of subjects with informed consent in the BENEFIT Extension study.
The safety analysis set included all patients who had at least one administration of study drug during BENEFIT.
The following statistical methods were used in the data analysis: follow-up study after premature discontinuation of the BENEFIT study. d Four lost to follow-up, 2 missing data, 1 non-compliance, 1 treatment failure, 2 refused final visit.
